Table 2.

Use of VL Testing by Calendar Year from 2010 to 2017 (n = 66,042 patients) ^a

	2010	2011	2012	2013	2014	2015	2016	2017
Total # of tests	11	9	84	970	826	864	17,549	20,221
# and % of unsuppressed tests	7 (63.6%)	4 (44.4%)	15 (17.9%)	408 (42.1%)	428 (51.8%)	306 (35.4%)	6988 (39.8%)	10,790 (53.4%)
Total # of patients active on ART	3913	8943	16,003	24,099	31,078	35,772	43,229	39,469
# and % of patients with at least 1 test	11 (0.3%)	9 (0.1%)	64 (0.4%)	951 (3.9%)	786 (2.5%)	839 (2.3%)	16,392 (37.9%)	18,828 (47.7%)
# and % of suppressed patients among patients with at least 1 test	4 (36.4%)	5 (55.6%)	51 (79.7%)	547 (57.5%)	378 (48.1%)	544 (64.8%)	9864 (60.2%)	8968 (47.6%)

^aYear 2017 includes data from January –September (9 months) only. Proportion shown of patients with at least one test is among active ART patients during the given calendar year